ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SHPH Shuttle Pharmaceuticals Holdings Inc

0.4119
0.01179 (2.95%)
최종 업데이트: 02:43:55
15분 지연
기업명 주식 심볼 시장 주식 타입
Shuttle Pharmaceuticals Holdings Inc SHPH 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01179 2.95% 0.4119 02:43:55
개장가 저가 고가 종가 전일 종가
0.4057 0.3904 0.4197 0.400108
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/05/202422:00EDGAR2Form 8-K - Current report
14/05/202422:00GLOBEShuttle Pharma Provides First Quarter 2024 Corporate Update
14/05/202406:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/04/202405:15GLOBEShuttle Pharmaceuticals to Present at the Planet MicroCap..
22/03/202422:00PRNUSShuttle Pharma Provides Fourth Quarter 2023 Corporate Update
09/03/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202423:00EDGAR2Form 8-K - Current report
13/02/202422:00EDGAR2Form 8-K - Current report
13/02/202422:00PRNUSShuttle Pharma Announces Its Intent to Pursue a Rights..
06/02/202406:25EDGAR2Form 8-K - Current report
24/01/202406:30PRNUSShuttle Pharma to Participate in a Fireside Chat at the..
08/01/202423:05EDGAR2Form 8-K - Current report
08/01/202423:00PRNUSShuttle Pharmaceuticals Receives FDA Approval to Proceed..
03/01/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202311:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202307:10EDGAR2Form 8-K - Current report
11/12/202323:00EDGAR2Form 8-K - Current report
11/12/202323:00PRNUSShuttle Pharmaceuticals Submits IND Application to the U.S...
30/11/202323:00EDGAR2Form 8-K - Current report
14/11/202323:00PRNUSShuttle Pharmaceuticals Provides Third Quarter 2023..
14/11/202306:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202322:00PRNUSShuttle Pharma Advances Prostate Cancer Predictive Biomarker..
31/10/202306:14EDGAR2Form 8-K - Current report
21/10/202305:15EDGAR2Form ARS - Annual Report to Security Holders
21/10/202305:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202322:00EDGAR2Form 8-K - Current report
10/10/202322:00PRNUSShuttle Pharma to Participate in the Lytham Partners Fall..
06/10/202305:10EDGAR2Form 8-K - Current report
25/09/202322:00EDGAR2Form 8-K - Current report
25/09/202322:00PRNUSShuttle Pharma Announces Results of Pre-IND Meeting with FDA..
13/09/202322:00PRNUSShuttle Pharma Participates in Hampton University Proton..
11/09/202322:00PRNUSShuttle Pharma Expands Patent Coverage on HDAC Inhibitor..
07/09/202322:20EDGAR2Form 8-K - Current report
29/08/202322:00PRNUSShuttle Pharma's Selective HDAC6 Inhibitor Shown to..
25/08/202303:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/08/202308:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202322:00EDGAR2Form 8-K - Current report
15/08/202322:00PRNUSShuttle Pharmaceuticals Provides Second Quarter 2023..
15/08/202305:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202322:00EDGAR2Form 8-K - Current report
03/08/202322:00PRNUSShuttle Pharmaceuticals Completes Manufacturing of Active..
26/05/202322:00PRNUSShuttle Pharmaceuticals Provides First Quarter 2023..
17/05/202322:00PRNUSShuttle Pharmaceuticals to Participate in the Lytham..

최근 히스토리

Delayed Upgrade Clock